1. A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy. Issue 4 (14th February 2014) Authors: Tolosa, Eduardo; Litvan, Irene; Höglinger, Günter U.; Burn, David; Lees, Andrew; Andrés, María V.; Gómez‐Carrillo, Belén; León, Teresa; del, Teodoro Journal: Movement disorders Issue: Volume 29:Issue 4(2014) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. Issue 4 (31st January 2014) Authors: Höglinger, Günter U.; Huppertz, Hans‐Jürgen; Wagenpfeil, Stefan; Andrés, María V; Belloch, Vincente; León, Teresa; del, Teodoro Journal: Movement disorders Issue: Volume 29:Issue 4(2014) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗